Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway.
Cutaneous inoculation of Loxosceles spp. spider venoms produces local necrosis, occasionally accompanied by systemic intravascular clotting and hemolysis. In this work, we analyzed the role of the C system on the lysis of human erythrocytes (Eh) induced by Loxosceles venoms in vitro. Eh were treated with whole venom of Loxosceles laeta, Loxosceles gaucho, or Loxosceles intermedia, or with purified venom proteins, and incubated with C-sufficient (Cs-NHS) or C9-depleted autologous (C9d-NHS) serum. Hemolysis was determined spectrophotometrically, and deposition of C components or removal of C regulatory proteins was analyzed by FACS. Eh suspensions exposed to venoms or to a purified 35-kDa protein from L. intermedia were lysed after incubation with Cs-NHS, but not with C9d-NHS. Lysis was blocked by heating the serum at 50 degrees C or Ca2+/Mg2+ chelation by EDTA, but not by Ca2+ chelation with EGTA. Deposition of C1, C2, C3, C4, C5, and factor B on the venom-treated Eh occurred during activation of autologous C. Regulatory proteins decay-accelerating factor (DAF) and CD59 were not altered significantly. Conversion of C-resistant Eh into C-susceptible Eh by the L. intermedia venom was accompanied by incorporation of a 35-kDa venom protein onto the cell surface. Thirty-five-kilodalton-related proteins were detected in the two other Loxosceles venoms by ELISA, using rabbit antiserum against the L. intermedia 35-kDa protein. These data suggest that the C system mediates the lysis of human erythrocytes and, by extension, of other cell types able to incorporate the lytic factor of Loxosceles venoms on their cell surfaces.
Tambourgi
D V
DV
Laboratório de Imunoquímica, Instituto Butantan, São Paulo, Brazil.
Magnoli
F C
FC
Von Eickstedt
V R
VR
Benedetti
Z C
ZC
Petricevich
V L
VL
da Silva
W D
WD
D000818:Animals; D018958:CD55 Antigens / Q000097:blood; D005591:Chemical Fractionation; D002850:Chromatography, Gel; D003170:Complement Pathway, Alternative / Q000187:drug effects*; D004912:Erythrocytes / Q000737:chemistry / Q000187:drug effects / Q000276:immunology*; D006460:Hemolysin Proteins / Q000302:isolation & purification / Q000494:pharmacology; D006461:Hemolysis / Q000187:drug effects / Q000276:immunology; D006801:Humans; D008565:Membrane Proteins / Q000097:blood / Q000494:pharmacology; D008970:Molecular Weight; D011817:Rabbits; D013111:Spider Venoms / Q000097:blood* / Q000494:pharmacology*
D018958:CD55 Antigens; D006460:Hemolysin Proteins; D008565:Membrane Proteins; D013111:Spider Venoms